Gene · 7220
Papers2,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates? | Pharmaceutics | 2022 | 36559052 | PubTator, text mining | PubMed |
| Astrocytes Reduce Store-Operated Ca2+ Entry in Microglia under the Conditions of an Inflammatory Stimulus and Muscarinic Receptor Blockade. | Pharmaceuticals (Basel) | 2022 | 36558972 | PubTator, text mining | PubMed |
| The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies. | Int J Mol Sci | 2022 | 36555369 | PubTator, text mining | PubMed |
| Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. | Cells | 2022 | 36552866 | PubTator, text mining | PubMed |
| TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. | Int J Mol Sci | 2022 | 36499683 | PubTator, text mining | PubMed |
| Thermo-Transient Receptor Potential Channels: Therapeutic Potential in Gastric Cancer. | Int J Mol Sci | 2022 | 36499622 | PubTator, text mining | PubMed |
| Similarities and Differences between the Orai1 Variants: Orai1α and Orai1β. | Int J Mol Sci | 2022 | 36498894 | PubTator, text mining | PubMed |
| Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? | Cancers (Basel) | 2022 | 36497413 | PubTator, text mining | PubMed |
| Suppression of Calcium Entry Modulates the Expression of TRβ1 and Runx2 in Thyroid Cancer Cells, Two Transcription Factors That Regulate Invasion, Proliferation and Thyroid-Specific Protein Levels. | Cancers (Basel) | 2022 | 36497320 | PubTator, text mining | PubMed |
| A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. | Nat Commun | 2022 | 36473860 | PubTator, text mining | PubMed |
| cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque. | Aging Dis | 2022 | 36465175 | PubTator, text mining | PubMed |
| TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca2+ leakage. | Nat Commun | 2022 | 36460692 | PubTator, text mining | PubMed |
| A review of the bioeffects of low-intensity focused ultrasound and the benefits of a cellular approach. | Front Physiol | 2022 | 36439246 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Neuroprotective Potential of Sacred Ficus Trees. | Nutrients | 2022 | 36432418 | PubTator, text mining | PubMed |
| Transient Receptor Potential (TRP) Channels in Tumor Vascularization. | Int J Mol Sci | 2022 | 36430727 | PubTator, text mining | PubMed |
| Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides. | Foods | 2022 | 36429288 | PubTator, text mining | PubMed |
| Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer. | Front Immunol | 2022 | 36389750 | PubTator, text mining | PubMed |
| An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. | Front Immunol | 2022 | 36389709 | PubTator, text mining | PubMed |
| Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M. | Sci Rep | 2022 | 36380063 | PubTator, text mining | PubMed |
| Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. | BMC Gastroenterol | 2022 | 36371178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7220/papers?page=17